Cited by 184Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationRetinoids in leukemia and cellular processes

Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells

Steidl, Ulrich, Rosenbauer, Frank, Verhaak, Roel G W, Gu, Xuesong, Ebralidze, Alexander, Otu, Hasan H, Klippel, Steffen, Steidl, Christian +10 more·2006·Nature Genetics

Abstract

Knockdown of the transcription factor PU.1 (encoded by Sfpi1) leads to acute myeloid leukemia (AML) in mice. We examined the transcriptome of preleukemic hematopoietic stem cells (HSCs) in which PU.1 was knocked down (referred to as 'PU.1-knockdown HSCs') to identify transcriptional changes preceding malignant transformation. Transcription factors c-Jun and JunB were among the top-downregulated targets. Restoration of c-Jun expression in preleukemic cells rescued the PU.1 knockdown-initiated myelomonocytic differentiation block. Lentiviral restoration of JunB at the leukemic stage led to loss of leukemic self-renewal capacity and prevented leukemia in NOD-SCID mice into which leukemic PU.1-knockdown cells were transplanted. Examination of human individuals with AML confirmed the correlation between PU.1 and JunB downregulation. These results delineate a transcriptional pattern that precedes leukemic transformation in PU.1-knockdown HSCs and demonstrate that decreased levels of c-Jun and JunB contribute to the development of PU.1 knockdown-induced AML by blocking differentiation and increasing self-renewal. Therefore, examination of disturbed gene expression in HSCs can identify genes whose dysregulation is essential for leukemic stem cell function and that are targets for therapeutic interventions.

Integrity signals

Registry

Crossref · 10.1038/ng1898

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Moderate PU.1 inhibition is common in AML patients.

    “yet moderate PU.1 inhibition is common in AML patients”
  • Development of myeloid leukemia in mice with decreased PU.1 expression is dependent on Jun.

    “The development of myeloid leukemia in mice that have decreased expression of PU.1 is dependent on Jun [27].”
  • Complete genetic ablation of PU.1 can yield a profound differentiation block that graduates to an AML-like phenotype.

    “While complete genetic ablation of PU.1 can yield a profound differentiation block that graduates to an AML-like phenotype (Steidl et al., 2006)”

    From PU.1 is required to restrain myelopoiesis during chronic inflammatory stress (2023) · cites this paper as Steidl et al., 2006

  • Several other transcriptional regulators interact with PU.1, including AP-1 family transcription factors.

    “Moreover, several other transcriptional regulators interact with PU.1, including AP-1 family transcription factors (Steidl et al., 2006; Boasman et al., 2019; Zhao et al., 2022).”

    From PU.1 is required to restrain myelopoiesis during chronic inflammatory stress (2023) · cites this paper as Steidl et al., 2006

  • The AP-1 factors c-Jun and JunB are critical interacting partners with PU.1 that also regulate myeloid differentiation, including PU.1 expression.

    “Indeed, the AP-1 factors c-Jun and JunB are also critical interacting partners with PU.1 that also regulate myeloid differentiation (including PU.1 expression) (Steidl et al., 2006; Raghav et al., 2018; Zhao et al., 2022).”

    From PU.1 is required to restrain myelopoiesis during chronic inflammatory stress (2023) · cites this paper as Steidl et al., 2006

The citation lists haven’t been fetched yet

References 50 · Cited by 184

Authors
Steidl, U., Rosenbauer, F., Verhaak, R. G. W., Gu, X., Ebralidze, A., Otu, H. H., Klippel, S., Steidl, C., Bruns, I., Costa, D. B., Wagner, K., Aivado, M., Kobbe, G., Valk, P. J. M., Passegué, E., Libermann, T. A., Delwel, R., & Tenen, D. G.
Affiliations
  • Harvard University (US)
  • Erasmus MC (NL)
  • Beth Israel Deaconess Medical Center (US)
  • Yeditepe University (TR)
  • University of Göttingen (DE)
  • Heinrich Heine University Düsseldorf (DE)
Corresponding author
Tenen, Daniel G
Venue
Nature Genetics
Published
2006-10-15
Volume
38
Issue
11
Pages
1269-1277
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2122742344
Cited by
184
References
50
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 14 · 2022: 4 · 2021: 9 · 2020: 5 · 2019: 12 · 2018: 7 · 2017: 9 · 2016: 4 · 2015: 5 · 2014: 11 · 2013: 20 · 2012: 11
FWCI
9.02
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
  • GRO (submittedVersion)
Funders
  • Lymphoma Research Foundation
  • National Institutes of Health
  • National Cancer Institute (CA 41456, R01CA041456)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
PU.1, acute myeloid leukemia, leukemia stem cells, hematopoietic stem cells, c-Jun, JunB, self-renewal, transcriptome, gene knockdown, NOD/SCID xenotransplantation
MeSH terms
Proto-Oncogene Protein Spi-1, Animals, Cell Differentiation, Cell Transformation, Neoplastic, Granulocytes, Hematopoietic Stem Cells, Humans, Monocytes, Proto-Oncogene Proteins, Transcription, Genetic, Transduction, Genetic, Leukemia, Myeloid, Acute, Trans-Activators, Down-Regulation, Mice, SCID, Mice, Inbred NOD, Proto-Oncogene Proteins c-jun, Mice, Knockout, Hematopoietic Stem Cell Transplantation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review